Serhat Çelik

12PUBLICATIONS
83CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyHaematologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 13, 2026
Is CMV PCR Monitoring Necessary in Patients with Hematological Malignancy Receiving Chemotherapy? A Prospective Single-Center Study

|Jan 28, 2026
Original Versus Generic Eltrombopag in Patients with Immune Thrombocytopenia: A Prospective Multi-Center Experience on Efficacy and Safety.

Serhat Çelik, Zeynep Tuğba Karabulut, Cem Selim

|Oct 29, 2025
Clinical Characteristics, Treatment Approaches, and Survival Predictors in Adult Acute Myeloid Leukemia: Interim Results from the Turkish Society of Hematology AML Registry.

Volkan Karakus, Ibrahim Ethem Pinar, Utku Iltar

|Oct 11, 2025
Comprehensive analysis of FLT3-mutated patients with acute myeloid leukemia with updated 2022 European LeukemiaNet recommendations: insights from the Turkish AML registry project.

Ibrahim Ethem Pinar, Serhat Celik, Merve Gokcen Polat

|May 19, 2025
The efficacy and safety of therapeutic thrombocytapheresis in patients with extreme thrombocytosis.

Serhat Çelik, Zeynep Tuğba Güven, Muzaffer Keklik

|Nov 06, 2024
Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis

Ünal Ataş, Ozan Salim, Utku Iltar

Pageof 2

Frequent Collaborators

8 joint publications

Muzaffer Keklik

5 joint publications

Zeynep Tuğba Karabulut

4 joint publications

Leylagül Kaynar

4 joint publications

İbrahim Ethem Pınar